Create your Personal Health Record and unlock support built around you
- Treatments and trials you qualify for
- Education for your stage of care
- Financial support for your medications
- Solutions to your side effects
ibrutinib
Tyrosine Kinase Inhibitors
Common brand names
- Imbruvica
Approved use in
- Multiple Myeloma
- B-Cell Prolymphocytic Leukemia
- Chronic Lymphocytic Leukemia
- Mantle Cell Lymphoma
- Marginal Zone Lymphoma
- T-Cell Prolymphocytic Leukemia
- Waldenström's Macroglobulinemia
Information about use in Blood Cancer
Information about use in B-Cell Prolymphocytic Leukemia
Information about use in Chronic Lymphocytic Leukemia
Information about use in Mantle Cell Lymphoma
Information about use in Marginal Zone Lymphoma
Information about use in T-Cell Prolymphocytic Leukemia
Information about use in Waldenström's Macroglobulinemia